Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Eur J Cardiothorac Surg ; 62(5)2022 10 04.
Article in English | MEDLINE | ID: mdl-35385074

ABSTRACT

OBJECTIVES: We evaluate the mid-term results of mitral valve (MV) repair with patch augmentation of the posterior leaflet in secondary mitral regurgitation. METHODS: Patients were included after diagnosis of a severe symptomatic secondary MV insufficiency with grade III and IV according to the Carpentier classification IIIb. Indication for a patch augmentation technique was a dilatation of the left ventricle leading to a displacement of the papillary muscles, causing restricted leaflet motion and a marked leaflet tenting height. Data were collected prospectively between December 2011 and March 2020. RESULTS: In total, 174 patients (mean age: 65 ± 12 years) received an MV repair with patch augmentation of the posterior leaflet and a true-sized remodelling annuloplasty (mean size 30.8 mm). Causes of the MV incompetence were dilatative cardiomyopathy in 126 patients and ischaemic myocardial disease in 48 patients. Concomitant bypass surgery was performed in 28 patients, and the tricuspid valve was repaired in 68 patients. The mean follow-up was 40 ± 28.2 months. There was no 30-day mortality. In-hospital mortality was 1.2% (n = 2); late mortality was 10.9% (n = 19). At 8 years, overall survival was 62.48%, freedom from moderate or severe recurrent mitral regurgitation was 91.9% and freedom from reoperation due to MV insufficiency was 97.1%. CONCLUSIONS: Augmentation of the posterior MV leaflet in addition to remodelling annuloplasty is a safe and reproducible mitral reconstruction technique that renders sustainable MV competence.


Subject(s)
Cardiac Surgical Procedures , Mitral Valve Annuloplasty , Mitral Valve Insufficiency , Humans , Middle Aged , Aged , Mitral Valve Insufficiency/etiology , Mitral Valve Insufficiency/surgery , Mitral Valve Insufficiency/diagnosis , Mitral Valve/diagnostic imaging , Mitral Valve/surgery , Papillary Muscles/surgery , Cardiac Surgical Procedures/methods , Tricuspid Valve , Dilatation, Pathologic , Treatment Outcome , Mitral Valve Annuloplasty/methods
2.
Eur J Cardiothorac Surg ; 57(6): 1122-1129, 2020 06 01.
Article in English | MEDLINE | ID: mdl-32011670

ABSTRACT

OBJECTIVES: There is an ongoing discussion about how to treat coronary stents during bypass surgery: Should patent stents be left alone and the stented vessels be ungrafted, or should every stented coronary artery receive a bypass graft? This study aims to determine the relevance of perioperative stent stenosis or occlusion on postoperative outcomes up to 3 years postoperatively. METHODS: Patients undergoing coronary artery bypass grafting surgery (CABG) (±concomitant procedures) with previous percutaneous coronary intervention from 4 centres were prospectively included in this observatory study between April 2015 and June 2017. A coronary angiography was conducted between the fifth and seventh postoperative days. The preoperative and postoperative angiograms were assessed in a core laboratory, assessing the patencies of coronary stents and bypass grafts. The core lab investigators were blinded to the patients' characteristics and perioperative course. RESULTS: A total of 107 patients were included in the study. In the postoperative coronary angiography, 265 bypass grafts and 189 coronary stents were examined angiographically. Ninety-seven percent of preoperatively patent stents remained patent. New coronary stent stenoses were observed in 5 patients (4.7%). All 5 patients were asymptomatic and managed conservatively. Bypass stenoses were observed in 12 patients (11%), of whom were managed conservatively, 4 underwent percutaneous coronary intervention and 1 underwent redo-CABG. Two years postoperatively, 97% of patients were alive. Patients with new stent stenosis tended to have a better survival compared with patients with bypass stenosis (100% vs 73%; P = 0.09) up to 3 years postoperatively. CONCLUSIONS: Perioperative coronary stent stenosis occurs rarely. It is safe to leave a patently stented coronary vessel without bypass grafting.


Subject(s)
Coronary Stenosis , Percutaneous Coronary Intervention , Constriction, Pathologic , Coronary Angiography , Coronary Artery Bypass/adverse effects , Humans , Percutaneous Coronary Intervention/adverse effects , Stents , Treatment Outcome
3.
Interact Cardiovasc Thorac Surg ; 26(5): 731-737, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29300989

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate the diagnostic possibilities of accurately locating the entry site in acute retrograde Type A aortic dissection and the results of the corresponding endovascular treatments. METHODS: Among 100 patients who underwent surgery for the treatment of spontaneous acute Type A aortic dissection between 2012 and June 2017, all but 1 patient had preoperative computed tomographic angiography. A total of 8 retrograde extensions originated from the descending aorta, in which 6 of them were diagnosed correctly using radiological imaging. The surgical team was unable to properly diagnose the entry site using radiological imaging in only 1 patient, and no preoperative computed tomographic-angiographic scans were available for 1 other patient. In the latter case, the retrograde dissection was diagnosed intraoperatively and confirmed by postoperative computed tomographic angiography. RESULTS: In 5 patients, a tear-oriented endovascular repair was performed based on preoperative radiological findings. In the remaining 3 patients, conventional surgery of the proximal aorta was performed because of the clinical situation (e.g. aortic insufficiency, pericardial effusion) and/or diagnostic uncertainty. One patient subsequently underwent an endograft successfully. All patients survived surgery and were alive at the last follow-up; however, complete remodelling of the thoracic aorta was evident in only patients with endovascular repair. CONCLUSIONS: Tear-oriented endovascular repair of acute Type A aortic dissection originating from the descending aorta seems to be a valuable and durable therapeutic option. However, the determination of the entry site in the descending aorta is a prerequisite for this type of treatment. Therefore, the surgical team should consider a diagnostics based on modern, sophisticated radiological methods.


Subject(s)
Aortic Aneurysm, Thoracic/diagnostic imaging , Aortic Aneurysm, Thoracic/surgery , Aortic Dissection/diagnostic imaging , Aortic Dissection/surgery , Blood Vessel Prosthesis Implantation , Endovascular Procedures , Aged , Aorta/surgery , Computed Tomography Angiography , Female , Humans , Male , Middle Aged , Radiography , Stents , Treatment Outcome
4.
J Thorac Cardiovasc Surg ; 155(4): 1414-1420, 2018 04.
Article in English | MEDLINE | ID: mdl-29342427

ABSTRACT

OBJECTIVES: The aim of the study was to evaluate operative techniques and long-term results after aortic valve or root repair in patients aged 75 years or more. METHODS: Between November 2002 and January 2016, a total of 815 patients underwent aortic valve or root repair. Among them were 100 patients aged 75 years or more (mean, 78 ± 3; range, 75-88 years), including 17 patients operated on an emergency basis because of acute aortic dissection. None/trivial, mild, moderate, and severe insufficiency grades were presented in 9, 23, 27, and 41 patients, respectively. The surgery comprised root repair, cusp repair, and a combination of both in 45, 16, and 39 patients, respectively. RESULTS: Early (30-day) mortality and the rate of permanent neurologic deficit were 2% for each. The follow-up was 99% complete, resulting in 427 patient/years. During the follow-up period (mean duration, 4.3 ± 3.2; range, 0.02-11.1 years), only 1 patient developed a relevant aortic insufficiency and required aortic valve reoperation. There were 24 late deaths, which occurred on average 50.0 ± 40.6 months (range, 2.4-135.0) after surgery at the average patient age of 82 ± 5 years (range, 75-90). Estimated survival at 5 and 8 years was 76.4% ± 5.1% and 71.3% ± 5.9%, respectively, and was similar to those of the sex- and age-matched general population. CONCLUSIONS: Reconstructive aortic valve surgery is a suitable and justifiable surgical option in selected elderly patients undergoing operation by surgeons with considerable experience in this kind of surgery. It offers low cardiac and valve-related mortality and morbidity, leading to life expectancy applicable to the patients' ages.


Subject(s)
Aortic Valve Insufficiency/surgery , Aortic Valve/surgery , Cardiac Surgical Procedures/methods , Plastic Surgery Procedures/methods , Age Factors , Aged , Aged, 80 and over , Aortic Valve/diagnostic imaging , Aortic Valve/physiopathology , Aortic Valve Insufficiency/diagnostic imaging , Aortic Valve Insufficiency/mortality , Aortic Valve Insufficiency/physiopathology , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/mortality , Echocardiography, Doppler, Color , Echocardiography, Transesophageal , Female , Hospital Mortality , Humans , Male , Postoperative Complications/mortality , Prospective Studies , Plastic Surgery Procedures/adverse effects , Plastic Surgery Procedures/mortality , Risk Factors , Severity of Illness Index , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...